More News
22 January 2018
Sanofi to Acquire Bioverativ for $11.6 Billion18 January 2018
Sandoz announces exclusive global collaboration with Biocon on next-generation biosimilars18 January 2018
X-Chem Enters Expanded Global Drug Discovery and Technology Transfer Collaboration with AstraZeneca9 January 2018
Scancell to collaborate with BioNTech to investigate T cell receptor based therapeutics for the treatment of cancer9 January 2018
Harbour BioMed Enters Agreement to Develop Fully Human Antibody Fragments for Innovative CAR-T Therapy9 January 2018
Incyte and Syros Announce Global Target Discovery and Validation Collaboration Focused on Myeloproliferative Neoplasms8 January 2018
Imcyse announces a research collaboration with Pfizer Inc. in rheumatoid arthritis (RA)8 January 2018
Celgene to Acquire Impact Biomedicines, Adding Fedratinib to Its Pipeline of Novel Therapies for Hematologic Malignancies8 January 2018
Sanofi and Alnylam enter into strategic restructuring of RNAi therapeutics rare disease alliance7 January 2018
Rebiotix and CoreBiome Collaborate on Evaluating Microbiomes of Patients Treated with Microbiota Restoration Therapy™7 January 2018
KBP Biosciences Raises $76 Million in Series A Financing and Appoints Brian P. McVeigh as Chief Executive Officer5 January 2018
Takeda and Denali Therapeutics Collaborate to Develop and Commercialize Therapies for Neurodegenerative Diseases5 January 2018
Takeda Announces Intention to Acquire TiGenix4 January 2018
Beacon Discovery announces multi-year GPCR-focused drug discovery collaboration with Janssen PharmaceuticalsNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports